Onkologie. 2011:5(3):138-140

RMG - Registry of Monoclonal Gammopathies

Vladimír Maisnar1,4, Jana Pelcová3,4, Daniel Klimeš2, Viera Sandecká3,4, Jakub Radocha1,4, Mária Klincová3,4, Roman Hájek3,4
1 II. interní klinika –, OKH, LF UK a FN Hradec Králové
2 Institut biostatistiky a analýz, MU Brno
3 Interní hematoonkologická klinika FN Brno
4 Česká myelomová skupina

Registry of monoclonal gammopathies together with the programme CRAB represent currently two main projects of the Czech Myeloma

Group. The purpose of this project is the prospective data analysis of monoclonal gammopathies patients in the region of the middle and

also the east Europe including incidence of diseases, therapeutical modalities used, the treatment results and the most frequent adverse

events of therapy. It is ambitious project which could help us to improve the care about patients with monoclonal gammopathies.

Keywords: monoclonal gammopathies, registry, multiple myeloma, diagnosis, therapy

Published: July 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maisnar V, Pelcová J, Klimeš D, Sandecká V, Radocha J, Klincová M, Hájek R. RMG - Registry of Monoclonal Gammopathies. Onkologie. 2011;5(3):138-140.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hájek R, Adam Z, Maisnar V, Ballová V, Kessler P, et al. Souhrn doporučení 2009, ,Diagnostika a léčba mnohočetného myelomu". Trans Hematol dnes 2009; Suppl. 2: 3-80.
    2. Pour L, Ščudla V, Gregora E, Maisnar V, Schützová M, et al. Dosavadní zkušenosti s léčbou lenalidomidem u pacientů s mnohočetným myelomem v ČR - pilotní data u vysoce předléčených nemocných. Onkologie 2009; 3: 311-313.
    3. Radocha J, Maisnar V, Sandecká V, Vávrová J, Spáčilová J, et al. Projekt MGUS 2010 - analýza dat 616 pacientů z registru RMG. Klin Biochem Metab 2010; 18: 80-82.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.